Human Diabetic Primary Gallbladder Fibroblast Cells

BVXDF006

$900.00
Starting Price
Human Diabetic Primary Gallbladder Fibroblast Cells
Primary Cells 1ml In Stock

Certified

Quality

Global

Shipping

Support

24/7

Info

Included

Product Details

$900.00
Quantity: 1
$900.00
Total price updates in real-time
Size

1ml

Product Code

BVXDF006

Request Custom Quote Add to Multi-Product Quote
Quick Specifications
  • Product Type: Human Type II Diabetes Endothelial Cells
  • Viability: >95% viable (Trypan Blue exclusion)
  • Storage: Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
  • Shelf Life: Very stable in the Liquid Nitrogen Vapor Phase
  • Catalog: BVXDF006
  • Growth: Primary cells capable of multiple passages when using recommended medium and proper handling

Human Diabetic Primary Gallbladder Fibroblast Cells

Product Description

Human Diabetic Primary Gallbladder Fibroblast Cells refer to specialized cells derived from the gallbladder of humans, specifically taken from individuals with diabetes. These fibroblasts play a crucial role in the structure and function of the gallbladder, contributing to tissue repair and fibrosis. Guarantee expansion for a minimum of 2-5 population doublings. IMPORTANT: Quality warranty requires use of Bioverax media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features & Benefits

Catalog Number: BVXDF006 Product Format: Frozen Vial Cell Number: > 5x10[5] cells/vial Passage:1(P1) Storage: Liquid Nitrogen, Vapor Phase Intended Use: Research use only (RUO) Characterization Markers - Characterized by spindle morphology under light microscopy. - Negative for von Willebrand Factor (vWF) , Cytokeratin 18, and alpha-smooth muscle actin . - Isolated and characterized to ensure fibroblast purity and identity.

Quick Facts
Product Type

Human Type II Diabetes Endothelial Cells

Viability

>95% viable (Trypan Blue exclusion)

Storage

Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).

Shelf Life

Very stable in the Liquid Nitrogen Vapor Phase

Applications
Diabetic Cholecystopathy: Diabetes is a major risk factor for gallstones (cholelithiasis) and 'acalculous' gallbladder disease. These cells help study how hyperglycemia affects gallbladder motility and wall stiffness. Wound Healing: Diabetic fibroblasts often exhibit delayed proliferation and altered cytokine secretion compared to non-diabetic controls. Drug Screening: Testing anti-fibrotic agents (e.g. metformin GLP-1 agonists) on cells that mimic the diabetic microenvironment.

Technical Specifications

Product Type Human Type II Diabetes Endothelial Cells
Viability >95% viable (Trypan Blue exclusion)
Proliferative Capability Primary cells capable of multiple passages when using recommended medium and proper handling
Storage Conditions Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase
Product Code BVXDF006
Size/Format 1ml
Category Primary Cells
Primary Applications
Diabetic Cholecystopathy: Diabetes is a major risk factor for gallstones (cholelithiasis) and 'acalculous' gallbladder disease. These cells help study how hyperglycemia affects gallbladder motility and wall stiffness. Wound Healing: Diabetic fibroblasts often exhibit delayed proliferation and altered cytokine secretion compared to non-diabetic controls. Drug Screening: Testing anti-fibrotic agents (e.g. metformin GLP-1 agonists) on cells that mimic the diabetic microenvironment.

Applications & Use Cases

Primary Applications
Diabetic Cholecystopathy: Diabetes is a major risk factor for gallstones (cholelithiasis) and 'acalculous' gallbladder disease. These cells help study how hyperglycemia affects gallbladder motility and wall stiffness. Wound Healing: Diabetic fibroblasts often exhibit delayed proliferation and altered cytokine secretion compared to non-diabetic controls. Drug Screening: Testing anti-fibrotic agents (e.g.

Suitable for diabetic cholecystopathy: diabetes is a major risk factor for gallstones (cholelithiasis) and 'acalculous' gallbladder disease. these cells help study how hyperglycemia affects gallbladder motility and wall stiffness. wound healing: diabetic fibroblasts often exhibit delayed proliferation and altered cytokine secretion compared to non-diabetic controls. drug screening: testing anti-fibrotic agents (e.g. studies and research applications

metformin

Suitable for metformin studies and research applications

GLP-1 agonists) on cells that mimic the diabetic microenvironment.

Suitable for glp-1 agonists) on cells that mimic the diabetic microenvironment. studies and research applications

Research Use Cases
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Technical Support & Documentation

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Docs
Shipping & Storage

Temperature-controlled shipping to 40+ countries.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Related Products